Related Experiment Videos
Screening, diagnosis, and management of dyslipoproteinemia in children
F A Franklin1, R F Brown, C C Franklin
1Department of Pediatrics, Louisiana State University School of Medicine, New Orleans.
Insights
Effective cardiovascular disease (CVD) reduction in children requires accessible screening for dyslipoproteinemia. Programs must include quality lipid measurements, risk classification, family involvement, and long-term adherence monitoring for diet and medications.
Area of Science:
- Pediatrics
- Cardiovascular Health
- Metabolic Disorders
Background:
- Dyslipoproteinemia is a significant risk factor for cardiovascular disease (CVD) in children.
- Early identification and management are crucial for long-term cardiovascular health.
- Current screening and management strategies require comprehensive review.
Purpose of the Study:
- To review dyslipoproteinemia in children.
- To outline an effective program for CVD risk reduction in pediatric populations.
- To emphasize key components for successful management.
Main Methods:
- Extensive and comprehensive literature review.
- Analysis of components for an effective pediatric CVD reduction program.
- Synthesis of recommendations for screening, diagnosis, and long-term follow-up.
Main Results:
- An effective program necessitates accessible screening to identify high-risk children.
- High-quality measurements of total cholesterol (TC) and lipoprotein cholesterol (LP-C) are essential.
- Careful follow-up, risk classification, and diagnosis of primary dyslipidemia are critical.
Conclusions:
- Family involvement and education play a key role in management.
- Consistent, long-term follow-up for adherence, efficacy, and safety of diet and drug interventions is vital.
- A multi-faceted approach is required for successful CVD risk reduction in children with dyslipoproteinemia.
Abstract:
The authors provide an extensive and comprehensive review of dyslipoproteinemia in children. An effective program for CVD reduction in this population will include an accessible screening program to identify high-risk children, high-quality measurements of TC and LP-C, careful follow-up of screening results with multiple measurement to classify risk status and diagnose primary dyslipidemia, a key role for family and education, and consistent and long-term follow-up for diet and drug adherence, efficacy, and safety.